Lunaphore is disrupting tissue diagnostics field by fundamentally changing the time and resource driven nature of diagnostic assays on tumor sections. Just like the fast sequencing technologies have made genomics testing possible for everybody today, Lunaphore will make possible an order-of-magnitude higher number of tissue biomarker checks for each tumor.

News

22.06.2023 Lunaphore joins the Bio-Techne family (startupticker.ch)
23.03.2023 Lunaphore raises CHF40 million (startupticker.ch)
30.06.2022 Startups conquer bigger markets (startupticker.ch)
10.05.2022 Lunaphore COMET European Deployment takes off (startupticker.ch)
06.08.2021 Startups ink new partnerships (startupticker.ch)
10.11.2020 Startups under new leadership (startupticker.ch)
16.09.2020 25 most promising scale-ups in Switzerland (venturelab.swiss)
15.06.2020 Lunaphore launches LabSat in four major markets (startupticker.ch)
21.04.2020 Swiss Entrepreneurs Fund invests in Lunaphore (startupticker.ch)
06.02.2020 Lunaphore receives CHF 23M Series C financing (startupticker.ch)

Documents

Videos and Presentations


Pitch Ata Tuna Ciftlik from Lunaphore @venture leaders kick-off event


venture leaders Interview with Ata Tuna Ciftlik from Lunaphore